Nivea Maker Beiersdorf Cuts Guidance for 2026, Citing Market Conditions
Beiersdorf trimmed its full-year guidance on Monday on slower-than-expected recovery at its core brand Nivea and other economic headwinds.
skincare
Beauty
CVC Buys Shiseido Personal-Care Unit in $1.5 Billion Deal
The Japanese beauty conglomerate is selling its shampoo and affordable skin care business for $1.5 billion as it shifts focus to high-end skin products.
CVC Buys Shiseido Personal-Care Unit in $1.5 Billion Deal
The Japanese beauty conglomerate is selling its shampoo and affordable skin care business for $1.5 billion as it shifts focus to high-end skin products.
The News in Brief
Soshe Launches at Ulta Beauty
The refillable clean makeup brand will enter the complexion category as it makes its debut across over 700 Ulta Beauty doors.
Shein Said to Weigh Cost Reset for Late Backers Before IPO
The retailer is considering lowering the investment cost for late backers who came in at a valuation of up to $64 billion as it prepares to list at a much lower value, people familiar with the matter said.
GLP-1 and Cosmeceutical Skincare Usage Spike Bathroom Mini Fridge Demand
As shoppers incorporate weight-loss drugs and more sophisticated skincare into their daily routines, a cottage industry is growing.
The Met’s Next Fashion Blockbuster Will Spotlight Galliano
The fashion icon, as famous for his singular talent as a scandal that cost him one of the industry’s top jobs, will become one of only three living designers to get a major solo exhibition at the museum.
Abbvie Earnings Beat Estimates as Botox Shows Signs of Revival
Abbvie reported second quarter profit and sales that topped expectations, driven by strong demand across its immunology and neuroscience franchises and further signs of a recovery in Botox.
Puma Results Show Progress on Turnaround
The German sports brand posted a narrower loss in the second quarter as it pushed ahead with an effort to restore growth next year.
DSM-Firmenich’s Fragrance-Led Core Profit Beat Sends Shares Higher
DSM-Firmenich beat market expectations for second-quarter core earnings, said full-year sales growth should reach the upper end of its target range on the back of broad-based volume growth.